Posts Tagged ‘ah1n1’
A(H1N1) Influenza Pandemic: Sanofi Pasteur’s Global Response
|
The scientific criteria for an influenza pandemic have been met. The world is now at the start of the 2009 influenza pandemic. Dr. Margaret Chan, Director General WHO – Many people found the SARS episode at the beginning of the 21st century very worrying at the time, but now a lot of people have forgotten about it. Then there was H5N1 and I think that since then, all the experts agree that it is no longer a question of if there will be a pandemic but when it will occur. Jacques Berger, President Sanofi Pasteur France – We feel prepared, we put together a plan that we are following and what's really good for us, and for public health is that this is following a process that has been really well established and something we are used to doing. Philip Hosbach, Vice President, Public Affairs, Sanofi Pasteur USA – The Val de Reuil site is authorized to produce this type of strain, the so-called pandemic strain. Because we had already produced several H5N1 type strains, so, even if this pandemic strain is of a different type, we were ready, we have procedures and processes in place that meant we could mobilise our resources much more quickly. Franck Chassant, Head of Flu Vaccine Production, Val de Reuil, Sanofi Pasteur France – Visit pandimic.influenza.com
|
From:sanofipasteurTV
Views:2203
![]() ![]() ![]() ![]() ![]() 2ratings
|
|
| Time:06:46 | More inScience & Technology |
RE: Polish Health Ministry on swine flu jabs issues A/H1N1 ( visit count unfroze again… :)
|
OK this is final version of that clip
|
From:maczikszcz
Views:
17152 ![]() ![]() ![]() ![]() ![]() 173
ratings |
|
| Time:09:13 | More inNews & Politics |
Baxter Completes Production Of First Commercial Batches Of A/H1N1 Pandemic Vaccine
Baxter International Inc. (NYSE: BAX) today announced that it completed production of its first commercial batches of CELVAPAN A/H1N1 pandemic vaccine in late July and is discussing plans for distribution with national health authorities, subject to obtaining appropriate authorizations. CELVAPAN, the brand name for the company’s A/H1N1 pandemic influenza vaccine, is made using Baxter’s proprietary Vero cell culture technology.
Inovio Biomedical Universal Influenza Vaccines Demonstrate 100% Protection Against Current Pandemic A/H1N1 Influenza Viruses In Animal Studies
Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced that the company’s SynCon? H1N1 influenza DNA vaccines achieved protection against current circulating swine origin influenza A/H1N1 viruses in animal studies.
33,902 Swine Flu A(H1N1) Cases Including 170 Deaths In USA
The Centers for Disease Control and Prevention (CDC) informed in its weekly update on Friday evening, 3rd July, 2009, that the total number of confirmed human cases of swine flu A(H1N1) infection stands at 33,902, including 170 deaths. In a Swine Flu conference held today in Cancun, Mexico, the World Health Organization (WHO) warned that the virus’ spread is now “unstoppable”.
Total Swine Flu A(H1N1) Human Infection Cases Reach 7,447 In The United Kingdom
The Health Protection Agency (HPA), UK, informed yesterday 3rd July, 2009, in its weekly update that the total number of confirmed human cases of Swine Flu A(H1N1) infection has reached 7,447. British health authorities estimate that the figure will be over 100,000 by the end of this summer.
Baxter Advances To Full-Scale Production Of A/H1N1 Vaccine
Baxter International Inc. (NYSE: BAX) announced that it has completed testing and evaluation of the A/H1N1 influenza virus and is now in full-scale production of a commercial A/H1N1 vaccine using its Vero cell culture technology. Baxter received an A/H1N1 strain from the U.S. Centers for Disease Control and Prevention [a World Health Organization (WHO) Collaborating Center] in early May and is diligently working to deliver a pandemic vaccine for use as early as July.
Over 15,510 Bird Flu A(H1N1) Human Cases Confirmed Worldwide, Including 99 Deaths
The WHO (World Health Organization) reported yesterday evening that the total number of swine flu A(H1N1) confirmed human cases of infection has exceeded 15,510, including 99 deaths. The real figure is higher because there is a delay between local health authority reports and the WHO global report. The A(H1N1) influenza virus is nowhere near as virulent (aggressive, dangerous) as was originally feared. Experts say it is not more deadly than normal seasonal human influenza.
Joint FAO/WHO/OIE Statement On Influenza A(H1N1) And The Safety Of Pork
To avoid any misunderstanding FAO, WHO and OIE would like to reissue their joint statement originally issued on 30 April 2009. In the ongoing spread of influenza A(H1N1), concerns about the possibility of this virus being found in pigs and the safety of pork and pork products have been raised. Influenza viruses are not known to be transmissible to people through eating processed pork or other food products derived from pigs.







